Non-European traditional herbal medicines in Europe: A community herbal monograph perspective

Journal of Ethnopharmacology

Volumn 156, Issue , 2014, Pages 107-114

  Qu, Liping ^a   Zou, Wenjun ^a   Zhou, Zhenxiang ^b   Zhang, Tingmo ^a   Greef, Janvander ^c   Wang, Mei ^c  

^a CHENGDU UNIVERSITY   (China)

^b HUBEI UNIVERSITY   (China)

^c Sino Dutch Centre for Preventative and Personalized Medicine and SU BioMedicine   (Netherlands)

Author keywords

Community herbal monograph; Directive 2004 24 EC; European legislation of herbal medicinal; Non European traditional herbal medicinal; products

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ANGELICA SINENSIS EXTRACT; CENTELLA ASIATICA EXTRACT; CHELIDONIUM EXTRACT; CICHORII INTYBI EXTRACT; CITRUS BERGAMIA EXTRACT; COMMIPHORA MOLMOL EXTRACT; EUPHRASIA OFFICINALIS EXTRACT; FOENICULUM VULGARE EXTRACT; GINGER EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; JUSTICIA ADHATODA EXTRACT; LINSEED OIL; ONION EXTRACT; PLANT EXTRACT; SALVIA OFFICINALIS EXTRACT; SYZYGIUM AROMATICUM EXTRACT; TARAXACUM OFFICINALE EXTRACT; TILIA TOMENTOSA EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; VISCUM ALBUM EXTRACT; WITHANIA SOMNIFERA EXTRACT; PLANT MEDICINAL PRODUCT;

AYURVEDA; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; EUROPE; HEALTH HAZARD; HERBAL MEDICINE; HUMAN; MEDICAL LITERATURE; NONHUMAN; REVIEW; SYSTEMATIC REVIEW; EUROPEAN UNION; LEGISLATION AND JURISPRUDENCE; MEDICINAL PLANT; PROCEDURES; PRODUCT SAFETY; TRADITIONAL MEDICINE;

CONSUMER PRODUCT SAFETY; EUROPE; EUROPEAN UNION; HERBAL MEDICINE; HUMANS; LEGISLATION, DRUG; MEDICINE, TRADITIONAL; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 84907221005     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.08.021     Document Type: Review

References (31)

1. Association of the European Self-Medication Industry Herbal medicinal products in the European Union Pharmaceuticals Policy and Law 2 1999 55 199
2. Barbara Steinhoff The first HMPC community herbal monographs Phytomedicine 13 2006 378 379
3. Commission of the European communities, 2008. Communication from the Commission to the Council and the European Parliament concerning the report on the experience acquired as a result of the application of the provisions of Chapter 2a of Directive 2001/83/EC, as amended by Directive 2004/24/EC, on specific provisions applicable to traditional herbal medicinal products. 〈http://eur-lex.europa.eu/legal-content/EN/ALL/;jsessionid=v7ryT4lPcvv3pd2xM1tgJ3QnHbdX1ltV1bTjpDtlv2RTbnLCwyFH!-1014547573?uri=CELEX:52008DC0584〉 (accessed 29.09.08).
4. Committee on herbal medicinal products, 2005a. Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/entries to the community list for traditional herbal medicinal products/substances/preparations. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003644.pdf〉 (accessed 7.09.06).
5. Committee on herbal medicinal products, 2005b. Procedure for the preparation of community monographs for traditional herbal medicinal products (revision 2). 〈http://www.ema.europa.eu/docs/en-GB/document-library/Regulatory-and-procedural-guideline/2009/12/WC500017012.pdf〉 (accessed 13.01.07).
6. Committee on herbal medicinal products, 2005c. Template for a Community herbal monograph (revision 6). 〈http://www.ema.europa.eu/docs/en-GB/document-library/Template-or-form/2009/12/WC500017411.pdf〉 (accessed 12.07.11).
7. Committee on herbal medicinal products, 2006a.Assessment report on Linum usitatissimum L., semen. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Herbal-HMPC-assessment-report/2010/01/WC500059156.pdf〉 (accessed 25.10.06).
8. Committee on herbal medicinal products, 2006b. Overview of assessment work - Priority list. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Other/2009/12/WC500017724.pdf〉 (accessed 22.11.13).
9. Committee on herbal medicinal products, 2007. Inventory of herbal substances for assessment. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Other/2009/12/WC500017723.pdf〉. (accessed 22.11.13).
10. Committee on herbal medicinal products, 2009a. Public statement on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, herba. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Public
11. Committee on herbal medicinal products, 2009b. Assessment report on Chelidoni ummajus L., herba. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Herbal-HMPC-assessment-report/2012/01/WC500120711.pdf〉 (accessed 13.09.11).
12. Committee on herbal medicinal products, 2009c. Assessment report on Centella asiatica (L.) Urban, herba. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Herbal-HMPC-assessment-report/2012/06/WC500128144.pdf〉 (accessed 25.11.10).
13. Committee on Herbal Medicinal Products, 2010. Reflection paper on the level of purification of extracts to be considered as herbal preparations. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2011/01/WC500100375.pdf〉 (accessed 16.09.10).
14. Committee on herbal medicinal products, 2011. HMPC work programme for 2012-2015. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Work-programme/2011/12/WC500119957.pdf〉 (accessed 16.11.11).
15. Committee on herbal medicinal products, 2012a. Report on 'Action plan for herbal medicines 2010-2011'. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Report/2012/06/WC500128647.pdf〉 (accessed 8.06.12).
16. Committee on herbal medicinal products, 2012b. Assessment report onZingiber officinale Roscoe, rhizoma. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Herbal-HMPC-assessment-report/2012/06/WC500128140.pdf〉 (accessed 27.03.12).
17. Committee on herbal medicinal products, 2012c. Assessment report on Angelica sinensis (Oliv.) Diels, radix. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Herbal-HMPC-assessment-report/2013/11/WC500155549.pdf〉 (accessed 9.07.13).
18. Committee on herbal medicinal products, 2012d. HMPC meeting report on Community herbal monographs, guidelines and other activities. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Committee-meeting-report/2012/11/WC500134490.pdf〉 (accessed 31.10.12).
19. Committee on herbal medicinal products, 2014. Questions & Answers on the EU framework for (traditional) herbal medicinal products, including those from a 'non-European' tradition. 〈http://www.ema.europa.eu/docs/en-GB/document-library/Regulatory-and-procedural-guideline/2014/05/WC500166358.pdf〉 (accessed 25.03.14).
20. Dutch Medicines Evaluation Board, 2012a. First Authorisation of Traditional Herbal Medicine from outside the European Union. http://www.cbg-meb.nl/CBG/en/human-medicines/actueel/First-Authorisation-of-Traditional-Herbal-Medicine-from-outside-the-European-Union/default.htm. (accessed 22.03.12).
21. Dutch Medicines Evaluation Board, 2012b. Public assessment report of Diao Xin Xue Kang capsules for oral use. 〈http://db.cbg-meb.nl/Pars/h102142.pdf〉 (accessed 14.03.12).
22. Elizabeth M. Williamson The rise of traditional Chinese medicine and its material medica: a comparison of the frequency and safety of materials and species used in Europe and China Journal of Ethnopharmacology 149 2 2013 453 462
23. European Commission, 2011. Q&A: Registration of Traditional Herbal Medicinal Products. 〈http://europa.eu/rapid/press-release-MEMO-11-71-en.htm〉 (accessed 4.02.11).
24. European medicines agency, 2011. Uptake of the traditional use registration scheme and implementation of the provisions of directive 2004/24EC in EU Member States (revision 3). 〈http://www.ema.europa.eu/docs/en-GB/document-library/Report/2011/05/WC500106706.pdf〉 (accessed 8.05.13).
25. Lida Teng Practice of traditional Chinese herbal medicine shops in central London Phytochemistry Letters 1 2008 94 98
26. Medicines and healthcare products regulatory agency
27. Medicines and Healthcare Products Regulatory Agency, 2013.UK Public assessment report ofpadmaCircosan capsules. 〈http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con266120.pdf〉 (accessed 22.02.13).
28. The European Parliament and the Council of the European Union, 2004. Directive 2004/24/EC amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. 〈http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0085:0090:en:PDF〉 (accessed 30.04.04).
29. J Van der Greef, and R.N McBurney Rescuing drug discovery and drug development: in vivo systems pathology and systems pharmacology Nature Reviews Drug Discovery 4 12 2005 961 967
30. J. Van der Greef Systems biology based diagnostic principles as pillars of the bridge between Chinese and Western medicine Planta Medica 76 2010 2036 2047
31. J Van der Greef Perspective: all systems go Nature 480 7378 2011 S87